These signature characteristics and having high-affinity CA IX targeting ligand of BSA-CDF-ATZ promotes the infiltration of the nanoparticles into the tumor through two mechanisms of EPR effect and active targeting, respectively [3,4]. The gene discussed is CA9; the disease is neoplasm.